DRREDDY vs LUPIN: Stock Comparison

DR. REDDY S LABORATORIES vs LUPINUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

DR. REDDY S LABORATORIES is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows lower leverage, while LUPIN shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DRREDDY leads 3; LUPIN leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DRREDDYLUPIN

Valuation lens

What price are you paying?

Market CapContext only
₹96,906 Cr
₹95,836 Cr
P/E RatioLUPIN has the lower reading
30.07x
17.33x
P/B RatioDRREDDY has the lower reading
2.56x
4.27x
EPSLUPIN has the higher reading
₹5.32
₹59.37
Book ValueContext only
₹458.03
₹492.38
Dividend YieldLUPIN has the higher reading
0.69%
0.86%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
DRREDDY is the larger company
₹96,906 Cr vs ₹95,836 Cr
P/E Ratio
LUPIN has a lower P/E
17.33x vs 30.07x
P/B Ratio
DRREDDY has a lower P/B
2.56x vs 4.27x
EPS
LUPIN has higher earnings per share
₹59.37 vs ₹5.32
Dividend Yield
LUPIN has a higher dividend yield
0.86% vs 0.69%
Revenue Growth (TTM YoY)
LUPIN has faster revenue growth
31.9% vs -11.6%
EPS Growth (TTM YoY)
LUPIN has faster EPS growth
89% vs -86.2%
Qtr Sales Growth
DRREDDY has stronger quarterly sales growth
57.69% vs -13.35%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYLUPIN
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricDRREDDYLUPIN
Live Price₹1,165.5₹2,095
Day Change1.97%0.83%
Volume24.03 L6.22 L
52-Week High₹1,414.9₹2,529.5
52-Week Low₹1,101₹1,900
Distance from 52W High-17.63%-17.18%

Valuation

MetricDRREDDYLUPIN
Market Cap₹96,906 Cr₹95,836 Cr
P/E Ratio30.07x17.33x
P/B Ratio2.56x4.27x
EPS₹5.32₹59.37
Book Value₹458.03₹492.38
Dividend Yield0.69%0.86%

Growth

MetricDRREDDYLUPIN
Revenue Growth (TTM YoY)-11.6%31.9%
EPS Growth (TTM YoY)-86.2%89%
Qtr Sales Growth57.69%-13.35%
Qtr Profit Growth7.64%91.58%

Profitability & Leverage

MetricDRREDDYLUPIN
ROE10.87%23.79%
ROCE10.31%23.47%
Net Margin12.76%17.65%
Operating Margin17.07%26.14%
Debt to Equity0.16x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDRREDDYLUPIN
Promoter Holding26.64% 0.01 pp46.57%
FII Holding32.07% 1.01 pp22.42% 0.71 pp
DII Holding31.74% 1.02 pp24.65% 0.67 pp
Public Holding9.35% 0.02 pp6.08% 0.03 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and LUPIN.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.